Rapid improvement of chronic stroke deficits with anti-TNF treatment

Chronic neurological dysfunction produced by stroke has long been thought to be irreversible. A new scientific discovery by Edward Tobinick MD, as documented in the video above, now promises to change current thinking about the potential for recovery of function, even years after the acute event.

This new patented treatment is available for new patients at the INR. For further information, please call the INR in Los Angeles at (310) 824-6199 or visit the INR Stroke website at www.strokebreakthrough.com.

Please see Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases. Edward Tobinick MD. CNS Drugs. 2011 Feb;25(2):145-155.

Disclaimer: Individual results vary, not all patients respond. Continuing maintenance treatment may be necessary to maintain the clinical response. Anti-TNF treatment for this indication is off-label. Please see the Terms of Use. The method of local etanercept treatment utilized is a patented invention of the INR. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311 and Australian patent 758523.